Josh has over fifteen years’ experience in quality assurance, clinical, preclinical and regulatory natural health products combined with extensive expertise in antibody and biologics development. He has been active in the probiotic community as a member of the International Probiotics Association (IPA) Board of Directors. He has been closely involved in both regulatory filings and the project management of clinical trials, which means he understands how regulatory bodies think. From 2011 to 2014, he represented the dietary supplement industry on a Health Canada expert working group working towards the harmonisation of safety reporting for supplements, drugs and biologics. Josh’s regulatory filings account for over ten percent of all applications received by Health Canada’s Natural and Non-prescription Health Products Directorate for clinical research trials.